Harout Semerjian
2021
In 2021, Harout Semerjian earned a total compensation of $2.9M as President and Chief Executive Officer at GlycoMimetics.
Compensation breakdown
| Bonus | $100,000 |
|---|---|
| Non-Equity Incentive Plan | $129,537 |
| Option Awards | $2,394,160 |
| Salary | $243,721 |
| Other | $8,700 |
| Total | $2,876,118 |
Semerjian received $2.4M in option awards, accounting for 83% of the total pay in 2021.
Semerjian also received $100K in bonus, $129.5K in non-equity incentive plan, $243.7K in salary and $8.7K in other compensation.
Rankings
In 2021, Harout Semerjian's compensation ranked 4,598th out of 12,415 executives tracked by ExecPay. In other words, Semerjian earned more than 63.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,598 out of 12,415 | 63rd |
Division Manufacturing | 1,906 out of 5,508 | 65th |
Major group Chemicals And Allied Products | 797 out of 2,378 | 67th |
Industry group Drugs | 711 out of 2,099 | 66th |
Industry Pharmaceutical Preparations | 506 out of 1,549 | 67th |
Source: SEC filing on April 11, 2022.
Semerjian's colleagues
We found three more compensation records of executives who worked with Harout Semerjian at GlycoMimetics in 2021.